Use access key #2 to skip to page content.
$1.06 0.00 (0.00%)
10/8/2008 1:56 PM

Simulations Plus, Inc. (SLP)

CAPS Rating:
**

The Company currently offers four software products for pharmaceutical research: ADMET Predictor/ ADMET Modeler, ClassPharmer, DDDPlus, and GastroPlus.

View All Commentary (SLP)

Recs

1

Avatar bigdividends (63.13) Submitted: 9/20/07 12:13 AM : Outperform Start Price: $6.85 SLP Score: -64.30

Carved themselves a nice niche in the health care software business. Company produce reserch software for the pharmaceutical industry. They have a number of predictor models which scientist are able to use to determine absorbtion rates and disolution of a drugs. A number of the larger players are starting to buy their software along with the U.S. National Institutes of Health (NIH).

Smart mangagement, good product and an expanding business sector. No long term debt, solid return on equity, excellent profit margins. They just announced a 2-1 stock split (dividend pay out).

Interesting to see what they do with there cash on hand. Numbers have gone from $1.6 mill at the end of august to almost double that at the end of may.

Report this Post Replies: 0 | Reply

Featured Broker Partners